List of Tables
Number of Products under Development for Parkinson’s Disease, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..5), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..6), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..7), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..8), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..9), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..10), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..11), H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..12), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017 (Contd..2), H1 2017
Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Products under Development by Companies, H1 2017 (Contd..3), H1 2017
Products under Development by Companies, H1 2017 (Contd..4), H1 2017
Products under Development by Companies, H1 2017 (Contd..5), H1 2017
Products under Development by Companies, H1 2017 (Contd..6), H1 2017
Products under Development by Companies, H1 2017 (Contd..7), H1 2017
Products under Development by Companies, H1 2017 (Contd..8), H1 2017
Products under Development by Companies, H1 2017 (Contd..9), H1 2017
Products under Development by Companies, H1 2017 (Contd..10), H1 2017
Products under Development by Companies, H1 2017 (Contd..11), H1 2017
Products under Development by Companies, H1 2017 (Contd..12), H1 2017
Products under Development by Companies, H1 2017 (Contd..13), H1 2017
Products under Development by Companies, H1 2017 (Contd..14), H1 2017
Products under Development by Companies, H1 2017 (Contd..15), H1 2017
Products under Development by Companies, H1 2017 (Contd..16), H1 2017
Products under Development by Universities/Institutes, H1 2017
Products under Development by Universities/Institutes, H1 2017 (Contd..1), H1 2017
Products under Development by Universities/Institutes, H1 2017 (Contd..2), H1 2017
Products under Development by Universities/Institutes, H1 2017 (Contd..3), H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..2), H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..3), H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..4), H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..5), H1 2017
Number of Products by Stage and Target, H1 2017 (Contd..6), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..1), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..2), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..3), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..4), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..5), H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017 (Contd..6), H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Parkinson’s Disease – Pipeline by 2-BBB Medicines BV, H1 2017
Parkinson’s Disease – Pipeline by 4P Therapeutics LLC, H1 2017
Parkinson’s Disease – Pipeline by AbbVie Inc, H1 2017
Parkinson’s Disease – Pipeline by AC Immune SA, H1 2017
Parkinson’s Disease – Pipeline by Acorda Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Adamas Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Addex Therapeutics Ltd, H1 2017
Parkinson’s Disease – Pipeline by Advinus Therapeutics Ltd, H1 2017
Parkinson’s Disease – Pipeline by Aeolus Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by AFFiRiS AG, H1 2017
Parkinson’s Disease – Pipeline by Amabiotics SAS, H1 2017
Parkinson’s Disease – Pipeline by Amarantus Bioscience Holdings Inc, H1 2017
Parkinson’s Disease – Pipeline by American Gene Technologies International Inc, H1 2017
Parkinson’s Disease – Pipeline by Anavex Life Sciences Corp, H1 2017
Parkinson’s Disease – Pipeline by Angita BV, H1 2017
Parkinson’s Disease – Pipeline by Antoxis Ltd, H1 2017
Parkinson’s Disease – Pipeline by Aoxing Pharmaceutical Company Inc, H1 2017
Parkinson’s Disease – Pipeline by APeT Holding BV, H1 2017
Parkinson’s Disease – Pipeline by ApoPharma Inc, H1 2017
Parkinson’s Disease – Pipeline by Aposense Ltd, H1 2017
Parkinson’s Disease – Pipeline by Araclon Biotech SL, H1 2017
Parkinson’s Disease – Pipeline by ArmaGen Inc, H1 2017
Parkinson’s Disease – Pipeline by Arrien Pharmaceuticals LLC, H1 2017
Parkinson’s Disease – Pipeline by Asceneuron SA, H1 2017
Parkinson’s Disease – Pipeline by AstraZeneca Plc, H1 2017
Parkinson’s Disease – Pipeline by Berg LLC, H1 2017
Parkinson’s Disease – Pipeline by Bial – Portela & Ca SA, H1 2017
Parkinson’s Disease – Pipeline by Bio-Modeling Systems SAS, H1 2017
Parkinson’s Disease – Pipeline by BioArctic AB, H1 2017
Parkinson’s Disease – Pipeline by Biogen Inc, H1 2017
Parkinson’s Disease – Pipeline by BioHealthonomics Inc, H1 2017
Parkinson’s Disease – Pipeline by Biopharm GmbH, H1 2017
Parkinson’s Disease – Pipeline by BrainStorm Cell Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Cantabio Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Cardax Inc, H1 2017
Parkinson’s Disease – Pipeline by Carna Biosciences Inc, H1 2017
Parkinson’s Disease – Pipeline by Cell Cure Neurosciences Ltd, H1 2017
Parkinson’s Disease – Pipeline by CHA Bio & Diostech Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by Chipscreen Biosciences Ltd, H1 2017
Parkinson’s Disease – Pipeline by Clera Inc, H1 2017
Parkinson’s Disease – Pipeline by Clevexel Pharma SAS, H1 2017
Parkinson’s Disease – Pipeline by ContraVir Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Corium International Inc, H1 2017
Parkinson’s Disease – Pipeline by Curemark LLC, H1 2017
Parkinson’s Disease – Pipeline by Daewoong Pharmaceutical Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by Denali Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Easywell Biomedical Inc , H1 2017
Parkinson’s Disease – Pipeline by Edison Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Eli Lilly and Company, H1 2017
Parkinson’s Disease – Pipeline by Ensemble Therapeutics Corp, H1 2017
Parkinson’s Disease – Pipeline by Evotec AG, H1 2017
Parkinson’s Disease – Pipeline by Fabre-Kramer Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Forma Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by FPRT Bio Inc, H1 2017
Parkinson’s Disease – Pipeline by Genecode AS, H1 2017
Parkinson’s Disease – Pipeline by Generon (Shanghai) Corp Ltd, H1 2017
Parkinson’s Disease – Pipeline by Genervon Biopharmaceuticals LLC, H1 2017
Parkinson’s Disease – Pipeline by GenKyoTex SA, H1 2017
Parkinson’s Disease – Pipeline by Genmab A/S, H1 2017
Parkinson’s Disease – Pipeline by Genzyme Corp, H1 2017
Parkinson’s Disease – Pipeline by H. Lundbeck A/S, H1 2017
Parkinson’s Disease – Pipeline by Heptares Therapeutics Ltd, H1 2017
Parkinson’s Disease – Pipeline by Herantis Pharma Plc, H1 2017
Parkinson’s Disease – Pipeline by Hisamitsu Pharmaceutical Co Inc, H1 2017
Parkinson’s Disease – Pipeline by HitGen LTD, H1 2017
Parkinson’s Disease – Pipeline by Huons Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by ICB International Inc, H1 2017
Parkinson’s Disease – Pipeline by Immungenetics AG, H1 2017
Parkinson’s Disease – Pipeline by Impel NeuroPharma Inc, H1 2017
Parkinson’s Disease – Pipeline by InnoMedica Holding AG, H1 2017
Parkinson’s Disease – Pipeline by Intec Pharma ltd, H1 2017
Parkinson’s Disease – Pipeline by InterMed Discovery GmbH, H1 2017
Parkinson’s Disease – Pipeline by International Stem Cell Corp, H1 2017
Parkinson’s Disease – Pipeline by Io Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Jeil Pharmaceutical Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by Kainos Medicine Inc, H1 2017
Parkinson’s Disease – Pipeline by Khondrion BV, H1 2017
Parkinson’s Disease – Pipeline by KineMed Inc, H1 2017
Parkinson’s Disease – Pipeline by Kissei Pharmaceutical Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by Kyowa Hakko Kirin Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by Lead Discovery Center GmbH, H1 2017
Parkinson’s Disease – Pipeline by Living Cell Technologies Ltd, H1 2017
Parkinson’s Disease – Pipeline by Longevity Biotech Inc, H1 2017
Parkinson’s Disease – Pipeline by Luye Pharma Group Ltd, H1 2017
Parkinson’s Disease – Pipeline by M et P Pharma AG, H1 2017
Parkinson’s Disease – Pipeline by M's Science Corp, H1 2017
Parkinson’s Disease – Pipeline by M3 Biotechnology Inc, H1 2017
Parkinson’s Disease – Pipeline by MedGenesis Therapeutix Inc, H1 2017
Parkinson’s Disease – Pipeline by MedImmune LLC, H1 2017
Parkinson’s Disease – Pipeline by Merck & Co Inc, H1 2017
Parkinson’s Disease – Pipeline by Metabolic Solutions Development Company LLC, H1 2017
Parkinson’s Disease – Pipeline by Minerva Neurosciences Inc, H1 2017
Parkinson’s Disease – Pipeline by Mission Therapeutics Ltd, H1 2017
Parkinson’s Disease – Pipeline by Mitochon Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Montisera Ltd, H1 2017
Parkinson’s Disease – Pipeline by Motac Neuroscience Ltd, H1 2017
Parkinson’s Disease – Pipeline by Neonc Technologies Inc, H1 2017
Parkinson’s Disease – Pipeline by Netherlands Translational Research Center BV, H1 2017
Parkinson’s Disease – Pipeline by Neuralstem Inc, H1 2017
Parkinson’s Disease – Pipeline by Neuraltus Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Neuren Pharmaceuticals Ltd, H1 2017
Parkinson’s Disease – Pipeline by NeuroDerm Ltd, H1 2017
Parkinson’s Disease – Pipeline by NeuroNascent Inc, H1 2017
Parkinson’s Disease – Pipeline by NeurOp Inc, H1 2017
Parkinson’s Disease – Pipeline by Neuropore Therapies Inc, H1 2017
Parkinson’s Disease – Pipeline by New World Laboratories Inc, H1 2017
Parkinson’s Disease – Pipeline by Newron Pharmaceuticals SpA, H1 2017
Parkinson’s Disease – Pipeline by nLife Therapeutics SL, H1 2017
Parkinson’s Disease – Pipeline by Novartis AG, H1 2017
Parkinson’s Disease – Pipeline by Novo Nordisk A/S, H1 2017
Parkinson’s Disease – Pipeline by NsGene A/S (Inactive), H1 2017
Parkinson’s Disease – Pipeline by Omeros Corp, H1 2017
Parkinson’s Disease – Pipeline by Oncodesign SA, H1 2017
Parkinson’s Disease – Pipeline by Ono Pharmaceutical Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by OPKO Health Inc, H1 2017
Parkinson’s Disease – Pipeline by Origenis GmbH, H1 2017
Parkinson’s Disease – Pipeline by Orion Oyj, H1 2017
Parkinson’s Disease – Pipeline by Oryzon Genomics SA, H1 2017
Parkinson’s Disease – Pipeline by Oxford BioMedica Plc, H1 2017
Parkinson’s Disease – Pipeline by ParkCell AB, H1 2017
Parkinson’s Disease – Pipeline by Parkure Ltd, H1 2017
Parkinson’s Disease – Pipeline by Peptron Inc, H1 2017
Parkinson’s Disease – Pipeline by Pfizer Inc, H1 2017
Parkinson’s Disease – Pipeline by Pharma Two B Ltd, H1 2017
Parkinson’s Disease – Pipeline by Pharmaxis Ltd, H1 2017
Parkinson’s Disease – Pipeline by Pharmicell Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by Pharnext SA, H1 2017
Parkinson’s Disease – Pipeline by Phenomenome Discoveries Inc, H1 2017
Parkinson’s Disease – Pipeline by Plex Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Prana Biotechnology Ltd, H1 2017
Parkinson’s Disease – Pipeline by Prexton Therapeutics SA, H1 2017
Parkinson’s Disease – Pipeline by Promentis Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Promius Pharma LLC, H1 2017
Parkinson’s Disease – Pipeline by Proteostasis Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Prothena Corp Plc, H1 2017
Parkinson’s Disease – Pipeline by reMYND NV, H1 2017
Parkinson’s Disease – Pipeline by Sage Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by SanBio Inc, H1 2017
Parkinson’s Disease – Pipeline by Saneron CCEL Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Saniona AB, H1 2017
Parkinson’s Disease – Pipeline by Serina Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Shire Plc, H1 2017
Parkinson’s Disease – Pipeline by Sigma-Tau SpA, H1 2017
Parkinson’s Disease – Pipeline by SignPath Pharma Inc, H1 2017
Parkinson’s Disease – Pipeline by Signum Biosciences Inc, H1 2017
Parkinson’s Disease – Pipeline by SK Biopharmaceuticals Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by STATegics Inc, H1 2017
Parkinson’s Disease – Pipeline by Stealth BioTherapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2017
Parkinson’s Disease – Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2017
Parkinson’s Disease – Pipeline by Sunovion Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Synthonics Inc, H1 2017
Parkinson’s Disease – Pipeline by Takara Bio Inc, H1 2017
Parkinson’s Disease – Pipeline by TauRx Therapeutics Ltd, H1 2017
Parkinson’s Disease – Pipeline by TechnoPhage SA, H1 2017
Parkinson’s Disease – Pipeline by Teikoku Pharma USA Inc, H1 2017
Parkinson’s Disease – Pipeline by Teva Pharmaceutical Industries Ltd, H1 2017
Parkinson’s Disease – Pipeline by Titan Pharmaceuticals Inc, H1 2017
Parkinson’s Disease – Pipeline by Trevena Inc, H1 2017
Parkinson’s Disease – Pipeline by UCB SA, H1 2017
Parkinson’s Disease – Pipeline by UniQure NV, H1 2017
Parkinson’s Disease – Pipeline by Varinel Inc, H1 2017
Parkinson’s Disease – Pipeline by VistaGen Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by VivaCell Biotechnology Espana SL, H1 2017
Parkinson’s Disease – Pipeline by Voyager Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by vTv Therapeutics Inc, H1 2017
Parkinson’s Disease – Pipeline by Wellstat Therapeutics Corp, H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..1), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..2), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..3), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..4), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..5), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..6), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..7), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..8), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..9), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..10), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..11), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..12), H1 2017
Parkinson’s Disease – Dormant Projects, H1 2017 (Contd..13), H1 2017
Parkinson’s Disease – Discontinued Products, H1 2017
Parkinson’s Disease – Discontinued Products, H1 2017 (Contd..1), H1 2017